• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DNA疫苗和鸡痘病毒疫苗接种猕猴中有效猿猴-人类免疫缺陷病毒特异性T细胞反应的表型和动力学分析

Phenotypic and kinetic analysis of effective simian-human immunodeficiency virus-specific T cell responses in DNA--and fowlpox virus-vaccinated macaques.

作者信息

Stratov Ivan, Dale C Jane, Kent Stephen J

机构信息

Department of Microbiology and Immunology, University of Melbourne, Parkville, Victoria 3010, Australia.

出版信息

Virology. 2005 Jul 5;337(2):222-34. doi: 10.1016/j.virol.2005.04.023.

DOI:10.1016/j.virol.2005.04.023
PMID:15907968
Abstract

Although T cell immunity is important in the control of HIV-1 infection, the characteristics of effective HIV-specific T cell responses are unclear. We previously observed protection from virulent SHIV challenges in macaques administered priming with DNA vaccines and boosting with recombinant fowlpox viruses expressing shared SIV Gag antigens. We therefore performed a detailed kinetic and phenotypic study of the T cell immunity induced by these vaccines prior to and following SHIV challenge utilizing intracellular cytokine staining. Pigtail macaques vaccinated intramuscularly with DNA/recombinant fowlpox virus exhibited a coordinated induction of first Gag-specific CD4 T cell responses and then a week later Gag-specific CD8 T cell responses following the fowlpox virus boost. Overall, the magnitude and timing of the peak CD8 T cell responses following challenge was significantly associated with reductions in SHIV viremia following pathogenic challenge. After pathogenic lentiviral challenge, virus-specific effector memory T cells derived from animals controlling SHIV infection recognized a broad array of epitopes, expressed multiple effector cytokines and rapidly recognized virus-exposed cells ex vivo. These results shed light on some of the requirements for T cells in the control of pathogenic lentiviral infections.

摘要

尽管T细胞免疫在控制HIV-1感染中很重要,但有效的HIV特异性T细胞反应的特征尚不清楚。我们之前观察到,在用DNA疫苗进行初次免疫并使用表达共享SIV Gag抗原的重组鸡痘病毒进行加强免疫的猕猴中,它们能够抵御强毒SHIV的攻击。因此,我们利用细胞内细胞因子染色技术,对这些疫苗在SHIV攻击之前和之后诱导的T细胞免疫进行了详细的动力学和表型研究。经肌肉注射DNA/重组鸡痘病毒疫苗接种的猪尾猕猴,在鸡痘病毒加强免疫后,首先出现了Gag特异性CD4 T细胞反应的协同诱导,一周后出现了Gag特异性CD8 T细胞反应。总体而言,攻击后CD8 T细胞反应峰值的大小和时间与致病性攻击后SHIV病毒血症的降低显著相关。在致病性慢病毒攻击后,来自控制SHIV感染动物的病毒特异性效应记忆T细胞识别广泛的表位,表达多种效应细胞因子,并在体外迅速识别病毒暴露细胞。这些结果揭示了T细胞在控制致病性慢病毒感染中的一些需求。

相似文献

1
Phenotypic and kinetic analysis of effective simian-human immunodeficiency virus-specific T cell responses in DNA--and fowlpox virus-vaccinated macaques.DNA疫苗和鸡痘病毒疫苗接种猕猴中有效猿猴-人类免疫缺陷病毒特异性T细胞反应的表型和动力学分析
Virology. 2005 Jul 5;337(2):222-34. doi: 10.1016/j.virol.2005.04.023.
2
Mucosally-administered human-simian immunodeficiency virus DNA and fowlpoxvirus-based recombinant vaccines reduce acute phase viral replication in macaques following vaginal challenge with CCR5-tropic SHIVSF162P3.经黏膜给药的人猿免疫缺陷病毒DNA和基于鸡痘病毒的重组疫苗,可降低猕猴经阴道接种CCR5嗜性SHIVSF162P3后急性期的病毒复制。
Vaccine. 2005 Oct 10;23(42):5009-21. doi: 10.1016/j.vaccine.2005.05.032.
3
Rapid appearance of secondary immune responses and protection from acute CD4 depletion after a highly pathogenic immunodeficiency virus challenge in macaques vaccinated with a DNA prime/Sendai virus vector boost regimen.在用DNA初免/仙台病毒载体加强免疫方案接种的猕猴中,高致病性免疫缺陷病毒攻击后,二次免疫反应迅速出现,并免受急性CD4细胞耗竭的影响。
J Virol. 2001 Dec;75(23):11891-6. doi: 10.1128/JVI.75.23.11891-11896.2001.
4
Efficient priming of simian/human immunodeficiency virus (SHIV)-specific T-cell responses with DNA encoding hybrid SHIV/hepatitis B surface antigen particles.用编码杂交猿猴/人类免疫缺陷病毒(SHIV)/乙型肝炎表面抗原颗粒的DNA有效启动SHIV特异性T细胞反应。
Vaccine. 2004 Sep 9;22(27-28):3535-45. doi: 10.1016/j.vaccine.2004.03.044.
5
Novel simian immunodeficiency virus CTL epitopes restricted by MHC class I molecule Mamu-B*01 are highly conserved for long term in DNA/MVA-vaccinated, SHIV-challenged rhesus macaques.受MHC I类分子Mamu - B*01限制的新型猿猴免疫缺陷病毒CTL表位在经DNA/MVA疫苗接种并受到SHIV攻击的恒河猴中长期高度保守。
Int Immunol. 2005 May;17(5):637-48. doi: 10.1093/intimm/dxh245. Epub 2005 Apr 11.
6
Subtype AE HIV-1 DNA and recombinant Fowlpoxvirus vaccines encoding five shared HIV-1 genes: safety and T cell immunogenicity in macaques.AE亚型HIV-1 DNA及编码五个共享HIV-1基因的重组鸡痘病毒疫苗:猕猴的安全性和T细胞免疫原性
Vaccine. 2005 Mar 14;23(16):1949-56. doi: 10.1016/j.vaccine.2004.10.012.
7
Comparative efficacy of subtype AE simian-human immunodeficiency virus priming and boosting vaccines in pigtail macaques.AE亚型猿猴-人类免疫缺陷病毒初免和加强疫苗在猪尾猕猴中的比较疗效
J Virol. 2007 Jan;81(1):292-300. doi: 10.1128/JVI.01727-06. Epub 2006 Oct 18.
8
Reduction of viral loads by multigenic DNA priming and adenovirus boosting in the SIVmac-macaque model.在SIVmac-猕猴模型中通过多基因DNA启动和腺病毒加强免疫降低病毒载量
Vaccine. 2006 Mar 10;24(11):1811-20. doi: 10.1016/j.vaccine.2005.10.026. Epub 2005 Oct 25.
9
Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.携带载体的Gag和Env而非Tat在Mamu - A*01阴性恒河猴中对猿猴 - 人类免疫缺陷病毒89.6P攻击显示出有效性。
J Virol. 2005 Oct;79(19):12321-31. doi: 10.1128/JVI.79.19.12321-12331.2005.
10
Efficacy of DNA and fowlpox virus priming/boosting vaccines for simian/human immunodeficiency virus.DNA和禽痘病毒初免/加强疫苗对猿猴/人类免疫缺陷病毒的疗效。
J Virol. 2004 Dec;78(24):13819-28. doi: 10.1128/JVI.78.24.13819-13828.2004.

引用本文的文献

1
Vector Order Determines Protection against Pathogenic Simian Immunodeficiency Virus Infection in a Triple-Component Vaccine by Balancing CD4 and CD8 T-Cell Responses.矢量顺序通过平衡 CD4 和 CD8 T 细胞应答来决定三重组件疫苗对致病性猴免疫缺陷病毒感染的保护作用。
J Virol. 2017 Nov 14;91(23). doi: 10.1128/JVI.01120-17. Print 2017 Dec 1.